Cargando…

Management of thymoma‐associated pure red cell aplasia: A novel use of blood substitute HBOC‐201 in a Jehovah’s Witness

Pure red cell aplasia (PRCA) is a rare paraneoplastic syndrome occasionally associated with thymomas. Here, we report on the first ever use of a bovine hemoglobin‐based oxygen carrier, HBOC‐201 (HbO2 Therapeutics LLC; Hemopure(®), Waltham, MA) for the supportive management of pure red cell aplasia i...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubinstein, Maria M., Goss, Cheryl, Avecilla, Scott T., Dubé, Gregory P., Riely, Gregory J., Mones, Jodi V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044386/
https://www.ncbi.nlm.nih.gov/pubmed/32128175
http://dx.doi.org/10.1002/ccr3.2626
_version_ 1783501560030953472
author Rubinstein, Maria M.
Goss, Cheryl
Avecilla, Scott T.
Dubé, Gregory P.
Riely, Gregory J.
Mones, Jodi V.
author_facet Rubinstein, Maria M.
Goss, Cheryl
Avecilla, Scott T.
Dubé, Gregory P.
Riely, Gregory J.
Mones, Jodi V.
author_sort Rubinstein, Maria M.
collection PubMed
description Pure red cell aplasia (PRCA) is a rare paraneoplastic syndrome occasionally associated with thymomas. Here, we report on the first ever use of a bovine hemoglobin‐based oxygen carrier, HBOC‐201 (HbO2 Therapeutics LLC; Hemopure(®), Waltham, MA) for the supportive management of pure red cell aplasia in a Jehovah Witness patient.
format Online
Article
Text
id pubmed-7044386
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70443862020-03-03 Management of thymoma‐associated pure red cell aplasia: A novel use of blood substitute HBOC‐201 in a Jehovah’s Witness Rubinstein, Maria M. Goss, Cheryl Avecilla, Scott T. Dubé, Gregory P. Riely, Gregory J. Mones, Jodi V. Clin Case Rep Case Reports Pure red cell aplasia (PRCA) is a rare paraneoplastic syndrome occasionally associated with thymomas. Here, we report on the first ever use of a bovine hemoglobin‐based oxygen carrier, HBOC‐201 (HbO2 Therapeutics LLC; Hemopure(®), Waltham, MA) for the supportive management of pure red cell aplasia in a Jehovah Witness patient. John Wiley and Sons Inc. 2019-12-26 /pmc/articles/PMC7044386/ /pubmed/32128175 http://dx.doi.org/10.1002/ccr3.2626 Text en © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Reports
Rubinstein, Maria M.
Goss, Cheryl
Avecilla, Scott T.
Dubé, Gregory P.
Riely, Gregory J.
Mones, Jodi V.
Management of thymoma‐associated pure red cell aplasia: A novel use of blood substitute HBOC‐201 in a Jehovah’s Witness
title Management of thymoma‐associated pure red cell aplasia: A novel use of blood substitute HBOC‐201 in a Jehovah’s Witness
title_full Management of thymoma‐associated pure red cell aplasia: A novel use of blood substitute HBOC‐201 in a Jehovah’s Witness
title_fullStr Management of thymoma‐associated pure red cell aplasia: A novel use of blood substitute HBOC‐201 in a Jehovah’s Witness
title_full_unstemmed Management of thymoma‐associated pure red cell aplasia: A novel use of blood substitute HBOC‐201 in a Jehovah’s Witness
title_short Management of thymoma‐associated pure red cell aplasia: A novel use of blood substitute HBOC‐201 in a Jehovah’s Witness
title_sort management of thymoma‐associated pure red cell aplasia: a novel use of blood substitute hboc‐201 in a jehovah’s witness
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044386/
https://www.ncbi.nlm.nih.gov/pubmed/32128175
http://dx.doi.org/10.1002/ccr3.2626
work_keys_str_mv AT rubinsteinmariam managementofthymomaassociatedpureredcellaplasiaanoveluseofbloodsubstitutehboc201inajehovahswitness
AT gosscheryl managementofthymomaassociatedpureredcellaplasiaanoveluseofbloodsubstitutehboc201inajehovahswitness
AT avecillascottt managementofthymomaassociatedpureredcellaplasiaanoveluseofbloodsubstitutehboc201inajehovahswitness
AT dubegregoryp managementofthymomaassociatedpureredcellaplasiaanoveluseofbloodsubstitutehboc201inajehovahswitness
AT rielygregoryj managementofthymomaassociatedpureredcellaplasiaanoveluseofbloodsubstitutehboc201inajehovahswitness
AT monesjodiv managementofthymomaassociatedpureredcellaplasiaanoveluseofbloodsubstitutehboc201inajehovahswitness